HC Wainwright & Co. Maintains Buy on Repligen, Raises Price Target to $208

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Repligen (NASDAQ:RGEN) with a Buy and raises the price target from $180 to $208.